Introduction: Despite significant morbidity and mortality from stroke, patient delays to emergency department (ED) presentation following the onset of stroke symptoms are one of the main contraindications to treatment for acute ischemic stroke (AIS). Our objective was to identify patient and environmental factors associated with delayed presentations to the ED after onset of stroke symptoms.
INTRODUCTION
Cerebrovascular disease is the fourth leading cause of death in the United States (U.S.) 1 For patients who survive a stroke, daily functionality may be permanently affected resulting in severe disability.
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What do we already know about this issue?
Patient delays in presentation to an emergency department (ED) are one of the main contraindications to treatment for acute ischemic strokes.
What was the research question?
Our objective was to identify patient and environmental factors associated with delayed presentations to the ED.
What was the major finding of the study? Time of day, patient language, cerebrovascular risk factors, and location of hospital were all significantly associated with delays in presentation.
How does this improve population health? Identifying barriers to prompt presentation to an ED following the onset of stroke symptoms is the first step in identifying how to best educate patients on stroke risk and recognition.
continue to be the main contraindication to using tPA for acute ischemic stroke (AIS). 4 Our prior work examining variation in adherence to guideline recommendations for administration of tPA for AIS identified that most patients were not eligible for tPA because they presented to the ED well outside the recommended treatment window. Thus, our objective was to identify patient and environmental factors that may contribute to delays in presentation following the onset of stroke symptoms in our patient population.
METHODS

Study Design
We conducted a pre-planned, secondary analysis of data from a multicenter, retrospective observational study evaluating variation in ED adherence to cardiovascular and cerebrovascular guidelines, including systemic thrombolysis for AIS. 5 The institutional review boards at each participating hospital approved the study with a waiver of consent.
Setting
This study was performed at three acute care hospitals in Colorado, including an urban safety-net hospital, a suburban, academic tertiary-care hospital, and a rural community hospital. All three EDs were staffed by board-certified/eligible emergency physicians. Annual adult ED census ranged from 55,000 to 80,000 patients at each hospital. Only the academic tertiary-care hospital was a certified Joint Commission Stroke Center. The rural community ED had neurologists available for consultation only by video, whereas the two other EDs had 24/7 in-house neurology consultation.
Population and Assembly of the Study Cohort
Consecutive patients were identified retrospectively by any hospital-discharge implantable cardioverter-defibrillator ICD-9 code for acute ischemic stroke (434.xx). 6 Investigators at each site obtained a list of consecutive patients with the above ICD-9 codes, who were admitted from the ED beginning on December 31, 2012. From this initial cohort, each unique patient encounter was screened by a physician abstractor for inclusion using the following criteria: 1) a discharge diagnosis in the medical record of acute ischemic stroke; 2) admission to the hospital from the ED; and 3) diagnosis or initiated treatment for AIS in the ED. Exclusion criteria were age <18 years and patients transferred from another facility. Patient encounters were screened until we obtained a sufficient sample (n=117) at each institution.
Data Collection
Once the study cohort was established, structured medical record abstraction was performed using established, standard methodology. 7, 8 Using a structured data abstraction form, abstractors documented the presence of pre-specified variables necessary to assess guideline adherence for tPA use in AIS, including time of symptom onset defined as last known normal (Appendix). In addition, patient sociodemographics, cerebrovascular comorbidities, stroke symptoms, arrival day and time were collected.
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We stratified patients' stroke risk into one of three groups depending on the cumulative number of stroke comorbidities: none, 1-2, and > 2. Patient chief complaints were stratified into three groups related to how typical the complaint was for stroke: typical for stroke (focal weakness, numbness, or alteration in speech); associated with stroke (headache, ataxia, dizziness, fall, seizure, vision change, altered mental status); and other.
Outcomes
Our primary outcome was whether a patient arrived in the ED within the "presentation window" for tPA for AIS. Guidelines for the use of tPA in AIS require that it be initiated with 4.5 hours of symptom onset. 3, 4 The American Heart Association/American Stroke Association (AHA/ASA) guidelines further recommend that tPA be initiated within 60 minutes of arrival to the ED. 4 Thus, patients who arrived within 3.5 hours of symptom onset were defined as having
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Data Management and Statistical Analyses
We performed all data management and statistical analysis using Statistical Analysis System (SAS) (SAS Institute, Inc., Cary, NC). Descriptive statistics were calculated for all variables. We reported continuous data as medians with interquartile ranges (IQR) and categorical variables as percentages with 95% confidence intervals (CI). A p-value < 0.05 was considered statistically significant. We assessed inter-rater reliability on the outcome variable using Cohen's kappa. A random sample of 15% of cases were reabstracted with near-perfect agreement (κ = 0.96).
We used unadjusted logistic regression to estimate the association of each patient and environmental variable with patient presentation to the ED within the treatment window. Hierarchical multivariable logistic regression was used to estimate associations between patient and environmental factors and presentation to the ED within the treatment window. We assessed effect modification between gender and chief complaint as well as language and chief complaint. Significant collinearity was identified between race and insurance as well as language and insurance; thus, we removed insurance from the final multivariable model.
Sample Size Estimation
The parent study was powered to estimate adherence variation from an a priori-defined 95% adherence threshold. 5 The parent study included 117 patients with AIS from each hospital, for a total 351 patients. Table 1 describes the sociodemographics, cerebrovascular comorbidities, and presenting characteristics of the 351 patients. The median time from symptom onset to presentation 
RESULTS
DISCUSSION
Despite the significant effect of stroke on morbidity and mortality in the U.S., much of the literature for AIS focuses on the importance of minimizing treatment delays in patients who present to the ED within the tPA treatment window.
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As acknowledged in a statement from the AHA, the weak link in applying stroke treatments is patient delay in seeking care. 20 Unfortunately, our results mirror those reported in the literature over the past 30 years, which show that the vast majority of patients are excluded from treatment due to delays in presentation. [20] [21] [22] [23] [24] [25] [26] [27] [28] We identified four possible barriers to prompt presentation to an ED in our cohort: primary language, stroke risk, time of day of ED presentation, and hospital location. Speaking a primary language other than English was significantly associated with delays in presentation to the ED. Two possible explanations for our finding include differences in knowledge and recognition of stroke symptoms, and reluctance to use emergency medical services (EMS) given a language barrier. 29, 30 We expected patients with known stroke-risk factors to present to the ED promptly. However, we found the opposite, which contrasts with Lacy who showed no association. 31 Given that we treated all risk factors equally in our analysis, it is possible that patients with less-obvious stroke comorbidities were unaware of their personal risk for stroke. 32, 33 The association of time of day and timing of ED presentation is likely explained by the effect of nocturnal onset of symptoms. Patients presenting in the morning after awakening with symptoms are almost always outside the treatment window as their last known normal time was their bedtime. 34, 35 While not specifically abstracted, we estimate that 12% of our cohort had "wake-up" strokes. Moreover, patients who presented in the evening hours were likely to have developed symptoms when family or co-workers were present to notice the symptoms. Lastly, it is not surprising that patients who present to a more rural hospital would have delays in presentation. While we do not have information on each patient regarding their exact distance traveled to each hospital in the study, it is reasonable to expect that patients presenting to more rural hospitals would have longer transport times than patients presenting to more urban hospitals.
36
LIMITATIONS
The primary limitation of this study was its use of secondary data. While these data captured the appropriate population to address our study objective, important confounders were not measured, namely EMS use and stroke severity, both of which have been shown to be associated with timing of arrival to the ED. [25] [26] [27] 37 
CONCLUSION
Important patient and environmental factors are significantly associated with delayed ED presentations following the onset of stroke symptoms. Identifying how best to educate patients on stroke risk and recognition remains critically important.
